Who owns Infinity Pharmaceuticals?

Key details on Infinity Pharmaceuticals (Ticker: INFI)

Who owns Infinity Pharmaceuticals?

Is INFI a good stock to own? Find out who bought Infinity Pharmaceuticals, who sold Infinity Pharmaceuticals (INFI) stock, and who holds a large position in Infinity Pharmaceuticals.

Fund Name Number of Shares Share Valuation As Of
OrbiMed Advisors 4.79M $66.21M Dec. 31, 2013
Deerfield Management Company 4.18M $57.75M Dec. 31, 2013
FMR 3.95M $54.52M Dec. 31, 2013
S.A.C. Capital Advisors 3.56M $49.10M Dec. 31, 2013
GOLDMAN SACHS 3.36M $46.35M Dec. 31, 2013
Quogue Capital 2.91M $101.68M Dec. 31, 2012
Vanguard 2.54M $35.05M Dec. 31, 2013
BVF 2.18M $19.31M Dec. 31, 2011
BlackRock Fund Advisors 2.05M $28.30M Dec. 31, 2013
STATE STREET CORPORATION 1.92M $26.55M Dec. 31, 2013
Wellington Management Company 1.70M $29.67M Sept. 30, 2013
BB Biotech AG 1.30M $17.96M Dec. 31, 2013
BlackRock Institutional Trust Company, N.A. 1.30M $17.96M Dec. 31, 2013
SUSQUEHANNA INTERNATIONAL 1.29M $17.80M Dec. 31, 2013
Broadfin Capital 996000 $13.75M Dec. 31, 2013
Visium Asset Management 951852 $13.15M Dec. 31, 2013
Oxford Asset Management 811331 $13.18M June 30, 2013
Ameriprise Financial 800613 $11.06M Dec. 31, 2013
QVT Financial 720947 $9.96M Dec. 31, 2013
Deutsche Bank Aktiengesellschaft 681160 $9.41M Dec. 31, 2013
NORTHERN TRUST 666348 $9.21M Dec. 31, 2013
T. Rowe Price Associates 610520 $8.43M Dec. 31, 2013
PointState Capital 605010 $21.18M Dec. 31, 2012
Baker Bros. Advisors 586936 $10.23M Sept. 30, 2013
Barclays 555453 $9.44M Sept. 30, 2013
BlackRock Advisors 526181 $7.27M Dec. 31, 2013
Franklin Resources 435200 $6.01M Dec. 31, 2013
ALLIANCEBERNSTEIN 426256 $20.66M March 31, 2013
Jefferies 421100 $21.05M March 31, 2013
First Eagle Investment Management 399499 $3.53M Dec. 31, 2011
CITADEL ADVISORS 397306 $13.91M Dec. 31, 2012
Credit Suisse AG 381251 $5.26M Dec. 31, 2013
DIMENSIONAL FUND ADVISORS 377773 $5.22M Dec. 31, 2013
Jennison Associates 372744 $6.50M Sept. 30, 2013
Millennium Management 361381 $4.99M Dec. 31, 2013
Chartwell Investment Partners 350150 $5.67M June 30, 2013
Perceptive Advisors 350000 $4.83M Dec. 31, 2013
Hambrecht & Quist Capital Management 349899 $4.83M Dec. 31, 2013
D. E. Shaw & Co 344969 $6.02M Sept. 30, 2013
Norges Bank Investment Management 343291 $4.74M Dec. 31, 2013
UBS GLOBAL ASSET MANAGEMENT AMERICAS 336219 $4.64M Dec. 31, 2013

Who sold Infinity Pharmaceuticals?

Fund Name Date Sold Number of Shares Sold Share Valuation
Wells Fargo & Company Sept. 30, 2011 868259 $5.79M
NEA Management Company June 30, 2011 876492 $7.24M